Iliad Biotechnologies, LLC

Seedlings Life Science Ventures, LLC

Steven Glazer

Keith Rubin

Kingston Mills

Marina Lynch

Keith H Rubin

Administering a live, attenuated-based vaccine to a subject at risk for developing a neurodegenerative disease featuring Aβ brain plaques can prevent or reduce the amount of Aβ brain plaques that would have developed in the subject without such treatment.

Treatment and prevention of neuropathology associated with neurodegenerative diseases

Progressive multifocal leukoencephalopathy (PML) has been identified in patients taking natalizumab (NMAB) for the treatment of multiple sclerosis (MS). This patent application provides a novel method of patient screening and monitoring intended to decrease the risk of PML and other opportunistic central nervous system (CNS) diseases in patients undergoing MS therapy with NMAB, and proposes a novel method of screening and monitoring intended to decrease the risk of opportunistic disease processes of the CNS during the treatment of other medical disorders with NMAB.

Growing community of inventors

Weston, CT, United States of America

Steven Glazer